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HCV induces transforming growth 
factor β1 through activation of 
endoplasmic reticulum stress and 
the unfolded protein response
Pattranuch Chusri1,2, Kattareeya Kumthip1,2, Jian Hong1, Chuanlong Zhu1,3, 
Xiaoqiong Duan1,4, Nikolaus Jilg1, Dahlene N Fusco1, Cynthia Brisac1, Esperance A Schaefer1, 
Dachuan Cai1,5, Lee F. Peng1, Niwat Maneekarn2, Wenyu Lin1 & Raymond T. Chung1
HCV replication disrupts normal endoplasmic reticulum (ER) function and activates a signaling network 
called the unfolded protein response (UPR). UPR is directed by three ER transmembrane proteins 
including ATF6, IRE1, and PERK. HCV increases TGF-β1 and oxidative stress, which play important roles 
in liver fibrogenesis. HCV has been shown to induce TGF-β1 through the generation of reactive oxygen 
species (ROS) and p38 MAPK, JNK, ERK1/2, and NFκB-dependent pathways. However, the relationship 
between HCV-induced ER stress and UPR activation with TGF-β1 production has not been fully 
characterized. In this study, we found that ROS and JNK inhibitors block HCV up-regulation of ER stress 
and UPR activation. ROS, JNK and IRE1 inhibitors blocked HCV-activated NFκB and TGF-β1 expression. 
ROS, ER stress, NFκB, and TGF-β1 signaling were blocked by JNK specific siRNA. Knockdown IRE1 
inhibited JFH1-activated NFκB and TGF-β1 activity. Knockdown of JNK and IRE1 blunted JFH1 HCV up-
regulation of NFκB and TGF-β1 activation. We conclude that HCV activates NFκB and TGF-β1 through 
ROS production and induction of JNK and the IRE1 pathway. HCV infection induces ER stress and the 
UPR in a JNK-dependent manner. ER stress and UPR activation partially contribute to HCV-induced 
NF-κB activation and enhancement of TGF-β1.
Over 170 million people worldwide are infected with hepatitis C virus (HCV), which is associated with 
chronic hepatitis, cirrhosis, and hepatocellular carcinoma1,2. HCV belongs to genus Hepacivirus in the family 
Flaviviridae. As with other positive-stranded RNA viruses, HCV has been shown to induce the formation of a 
membrane-associated replication complex3. HCV proteins have been shown to associate with endoplasmic retic-
ulum (ER) membranes. The envelope glycoproteins (E1, E2) have been shown to associate with ER membranes 
through their transmembrane domains4. In addition, HCV NS4B has been demonstrated to induce the formation 
of a membranous web5,6, which derives from the ER membrane7 and mediates HCV RNA replication8. HCV rep-
lication in the ER also likely stimulates the ER stress response pathway9. Upon sensing ER stress, HCV-infected 
cells activate a cytoprotective signaling cascade called the unfolded protein response (UPR)10. The UPR is directed 
by three ER-localized transmembrane proteins, activating transcription factor 6 (ATF6), inositol-requiring pro-
tein (IRE1), and protein kinase RNA-like endoplasmic reticulum kinase (PERK). When misfolded proteins accu-
mulate in the ER, ATF6 is translocated from the ER to the Golgi, and then the full-length ATF6 is processed by 
sphingosine 1-phosphate (S1P) and sphingosine 2-phosphate (S2P) proteases to produce a cytosolic ATF611. This 
cytoplasmic form of ATF6 is an active transcription factor, which is translocated into the nucleus and induces 
the transcription of ER stress response genes12. Activation of IRE1 by ER stress leads to homodimerization and 
transphosphorylation of IRE113. The activated IRE1 splices the unspliced X-box protein-1 (XBP-1u) mRNA into 
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its spliced form (XBP-1s). The XBP-1s protein functions as a transcriptional activator of UPR genes that con-
tain the unfolded protein responsive elements (UPREs) and ER-associated degradation (ERAD)-related genes14. 
PERK is an ER-resident transmembrane protein and is activated in a similar manner as IRE115. The activated 
PERK subsequently phosphorylates eukaryotic translation initiation factor 2α (eIF2α ) and leads to inhibition of 
translation initiation16.
Transforming growth factor β (TGF-β 1) plays a major pathophysiological role in fibrogenesis and growth 
dysregulation in cancerous and apoptotic cells17. Patients with chronic HCV infection have higher levels of 
TGF-β 1, both total and biologically active forms, compared with healthy controls. Immunohistochemical stain-
ing of liver sections revealed that 62% of HCV patients have TGF-β 1 present in sinusoidal cells of liver tissue18. 
Elevated serum levels of TGF-β 1 have been found in chronic HCV-infected patients, as compared to healthy 
controls19. In addition, HCV core induced TGF-β 1 transcription upregulation has been shown in cell lines20. 
HCV JFH-1 infection in Huh-7 cells induces transcriptional stimulation, synthesis, and secretion of bioactive 
TGF-β 1 in a time-dependent manner21. We have previously demonstrated that the JFH-1 cell culture infectious 
HCV induces TGF-β 1 through the generation of reactive oxygen species (ROS) and p38 MAPK, JNK, ERK1/2, 
NFκ B-dependent pathways2,22,23. However, the mechanism by which HCV-induced ER stress, UPR activation, 
and TGF-β 1 production are linked has not been fully characterized. We therefore sought to determine whether 
HCV induces TGF-β 1 production through ER stress and UPR activation pathways using the infectious JFH1 
HCV replication model. We hypothesized that HCV induction of TGF-β 1 is mediated by ER stress and the UPR.
Results
HCV infection induces the antioxidant response, ER stress, NFκB, and TGF-β1 gene expres-
sion. The induction of ROS, ER stress, NFκ B, and TGF-β 1 in JFH1 HCV-infected Huh7.5.1 cells was exam-
ined and compared to uninfected cells. Cells were infected with JFH1-HCV and viral replication was assessed 
Figure 1. HCV infection induced antioxidant response, ER stress, NFκB, and TGF-β1 in a time dependent 
manner. Huh7.5.1 cells were infected with JFH1 HCV virus. After 24, 72, 120, and 168 hours of infection cells 
were transfected with plasmid pARE-luciferase, pERSE-luciferase, pNFκ B-luc or pSMAD-luciferase reporter. 
The pRL-TK expressing Renilla luciferase was co-transfected as an internal control. ER stress pathway was 
monitored by a dual luciferase reporter assay system at 24 hours after transfection. HCV infection increased 
Nrf2/1, ERSE, NFκ B, and SMAD luciferase signaling by 6.7, 8.4, 2.8, and 4.7-fold, respectively compared with 
un-infected Huh 7.5.1 cells (Fig. 1A–D). Relative luciferase activity (RLA) was normalized by dividing the firefly 
luciferase value by the Renilla luciferase value. *p < 0.05; and **p < 0.01 compared with un-infected Huh7.5.1 
cells. Empty bar: Huh 7.5.1 cells, Black bar: JFH1-infected Huh 7.5.1 cells.
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by qRT-PCR. We studied whether HCV infection induced ROS, ER stress, NFκ B, and TGF-β 1 signaling. We 
measured the effects of JFH1-HCV on Nrf2/1, ERSE, NFκ B, and TGF-β 1-mediated transcriptional activity using 
a luciferase reporter construct containing the corresponding functional binding site. HCV infection increased 
pARE luciferase signaling in HCV-infected Huh7.5.1 cells by 6.7-fold compared with un-infected Huh7.5.1 cells 
at day 3 of infection (p = 0.007; Fig. 1A). The pARE reporter was designed to measure the transcriptional activity 
of the Nrf2 and Nrf1 transcription factors. Nrf2 and Nrf1 act as sensors for oxidative stress and direct transcrip-
tion from the antioxidant response element (ARE). HCV increased pERSE-luciferase signaling in JFH1 cells by 
8.4-fold compared with Huh7.5.1 cells at day 3 of infection (p = 0.003; Fig. 1B). The ERSE reporter monitored 
activity of the endoplasmic reticulum (ER) stress pathway. HCV infection increased NFκ B signaling in JFH1 cells 
by 2.8-fold compared with Huh7.5.1 cells (p = 0.022; Fig. 1C). The NFκ B-responsive luciferase construct encodes 
the firefly luciferase reporter gene under the control of a CMV promoter and tandem repeats of the NFκ B tran-
scriptional response element (TRE). HCV infection increased pSMAD luciferase signaling in HCV-infected 
Huh7.5.1 cells by 4.7–fold compared with un-infected Huh7.5.1 cells (p = 0.013; Fig. 1D). The SMAD reporter 
construct was designed to monitor the activity of TGF-β -induced signal transduction pathways. TGF-β signaling 
induces phosphorylation and activation of the SMAD2 and SMAD3 proteins, which then form complexes with 
SMAD4 and translocate to activate the expression of TGFβ -responsive genes.
HCV infection activated each of the three arms of the UPR. We next examined the induction of 
the UPR in uninfected or JFH1 HCV-infected Huh7.5.1 cells over a 7-day time course. Each of the three arms 
of the UPR was activated in a wave-like pattern. We found that JFH1-HCV infection increased levels of the 
cleaved active form of ATF6 that peaked at day 3. The IRE1 pathway was also induced in JFH1-infected cells. 
Phosphorylated PERK was also detected in Huh7.5.1 cells infected with JFH1 (Fig. 2A). The level of spliced 
Figure 2. HCV infection activated each of the three arms of the UPR in a time dependent manner. Huh 
7.5.1 cells were infected with HCV-JFH1. Following 24, 72, 129, and 168 hours of infection, protein was 
extracted at the indicated time points. The expression of phospho-IRE1, phospho-PERK, and cleaved ATF6 
were analyzed by western blot. JFH1 HCV infection increased levels of phospho-IRE1, phospho-PERK, and the 
cleaved active form of ATF6 (Fig. 2A). Gene expression levels of spliced XBP-1, ATF3, and ATF4 at day 1, 3, 5, 
and 7 of infection were determined by real-time PCR and normalized to GAPDH. We found that the spliced 
XBP-1 mRNA level in JFH1-infected Huh7.5.1 cells increased by 2.7-fold at day 3 post infection compared to 
uninfected Huh7.5.1 cells (Fig. 2B). The spliced ATF3, and ATF4 mRNA levels were elevated by 20.5, 5.8-fold, 
respectively, in JFH1-infected Huh7.5.1 cells at day 3 post-infection compared to uninfected Huh7.5.1 cells  
(Fig. 2C,D). *p < 0.05; **p < 0.01; and #p < 0.001 compared between JFH1-infected and un-infected Huh7.5.1 
cells. Empty bar: Huh 7.5.1 cells, Black bar: JFH1-infected Huh 7.5.1 cells.
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XBP-1s mRNA was significantly elevated at day 3 compared to uninfected cells (Fig. 2B). Similarly, mRNA lev-
els of ATF3 and ATF4 were up-regulated by 20.5 and 5.8 fold, respectively, at the same time point compared to 
uninfected cells (Fig. 2C,D) (p = 0.001, 0.008). These data indicate that HCV induces each of the three arms of the 
UPR, including ATF6, IRE1α , and PERK.
ROS and JNK inhibitors block HCV up-regulation of ER stress and UPR activation. To deter-
mine how HCV induces the ER stress and UPR pathways, we assessed the activity of ARE and ERSE reporters in 
un-infected or JFH1-infected cells treated with several different pathway inhibitors. DPI, a blocker of ROS forma-
tion, decreased HCV-induced ARE and ERSE signaling, compared with JFH1-infected Huh7.5.1 cells (Fig. 3A,B, 
p = 0.014, and 0.018, respectively). The JNK inhibitor SP also blocked ERSE signaling in JFH1-infected Huh7.5.1 
cells (Fig. 3B, p = 0.005). None of the tested inhibitors had an effect on cell viability (Fig. 3C). Additionally, 
HCV-induced XBP1s, ATF3 and ATF4 mRNA expression were reduced by DPI and SP (Fig. 4A–C, respectively). 
At the protein level, the ROS inhibitor DPI decreased the HCV-induced phosphorylation of p38MAPK, JNK, 
ERK, IRE1, PERK and the cleaved form of ATF6. Furthermore, the JNK inhibitor SP blocked HCV-induced IRE1, 
PERK phosphorylation and ATF6 cleavage (Fig. 4D). These data indicate that HCV promotes ROS generation and 
subsequently activates ER stress through the JNK pathway. We also found that IREstatin reduced HCV-induced 
XBP-1 (p = 0.047), and GSK inhibited HCV-induced ATF3 and ATF4 mRNA (p = 0.044, and 0.045, respectively) 
enhancement. These findings suggest that IRE1 is in the upstream of XBP-1 and PERK is upstream of ATF3 and 
ATF4.
ROS, JNK and IRE1 inhibitors block HCV-activated NFκB and TGF-β1. The effects of several dif-
ferent pathway inhibitors on NFκ B and TGFβ -mediated transcriptional activity were measured using a lucif-
erase reporter construct in JFH1-HCV-infected and uninfected Huh7.5.1 cells. We found that ROS inhibitor 
DPI and the NFκ B inhibitor AQ each completely blocked HCV-induced NFκ B and TGF-β 1 induced-SMAD 
signaling (Fig. 5A, p = 0.007, and 0.035, respectively; Fig. 5B, p = 0.008, and 0.040, respectively). SP, SB, U0126 
and IREstatin partially reduced HCV-induced NFκ B signaling (p = 0.004, 0.047, 0.045 and 0.029, respectively) 
Figure 3. ROS and JNK inhibition decreased HCV-induced ER stress and UPR activation. Huh7.5.1 
cells and Huh7.5.1 infected with JFH1 for 3 days were transfected with plasmid pARE or pERSE-luciferase 
reporter. The pRL-TK expression Renilla luciferase was co-transfected as an internal control. After 24 hours 
of transfection, cells were treated with several pathway inhibitor including DPI, SB, SP, U0126, LY, AEBSF, 
IREstatin, and GSK at 20 μM each. 1% DMSO was used as a negative control. ARE-mediated Nrf2 and ER 
stress signaling pathway were monitored by dual luciferase reporter assay at 24 hours after inhibitor treatment. 
Relative luciferase activity (RLA) was normalized by dividing the firefly luciferase value by the Renilla luciferase 
value. DPI (ROS inhibitor) decreased HCV-induced ARE signaling in JFH1-infected Huh7.5.1 cells. DPI and 
SP (JNK inhibitor) blocked HCV-induced ERSE signaling in JFH1-infected cells (Fig. 3A,B). There was no 
significant difference in proliferation between untreated and inhibitor treated cells at 6, 12, 24, and 48 hours of 
the treatment (Fig. 3C). **p < 0.01 for comparison of indicated treatment to the JFH1-infected cells in DMSO.
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and partially reduced HCV-induced TGF-β signals (p = 0.043, 0.031, 0.033 and 0.025, respectively). Furthermore, 
HCV-induced TGF-β 1 mRNA expression enhancement was completely blocked by DPI or AQ, and partially 
inhibited by SP, SB, U0126 and IREstatin (Fig. 5C, p = 0.006, 0.044, 0.020). Additionally, immunoblotting showed 
that DPI and AQ each completely blocked HCV-induced NFκ B phosphorylation, SP, SB, U0126, and IREstatin 
partially decreased JFH1-induced NFκ B phosphorylation (Fig. 5D). Taken together, our data suggest that IRE1 
plays a partial role in the induction of NFκ B and TGF-β 1 during HCV infection. These data show that HCV acti-
vates NFκ B and TGF-β 1 through ROS production and partial through induction of JNK and the IRE1 pathway.
siRNA-mediated knockdown of JNK and IRE1 inhibited JFH1 HCV activated ER stress, 
NFκB, and TGF-β1 luciferase activity. Based on our data above, we sought to further assess whether 
IRE1 was responsible for the induction of NFκ B and TGF-β 1 in HCV infection. To accomplish this, luciferase 
reporter experiments were performed to analyze levels of Nrf2/1, ERSE, NFκ B, and TGF-β 1-mediated tran-
scriptional activity after siRNA-mediated knockdown of JNK, IRE1, ATF6, and PERK in Huh7.5.1 cells either 
mock-infected or infected with HCV. To confirm that HCV induces NFκ B and TGF-β 1 expression through a 
ROS production-JNK-IRE1 pathway, the ROS, ER stress, NFκ B, and TGF-β 1 promoter-driven luciferase activity 
were monitored in JFH1-infected cells transfected with siRNA-mediated knockdown of JNK, IRE1, ATF6, and 
PERK. We found that ON-TARGET plus SMART pool human siRNAs exhibited stronger mRNA knockdown 
effects compared to individual siRNA species (Fig. 6A–D). We found that ARE signaling was not affected by 
siRNA against JNK, IRE1, ATF6, and PERK (Fig. 7A). ERSE signaling was completely blocked by siRNA against 
Figure 4. ROS and JNK inhibition decreased HCV-induced ER stress and UPR activation. Huh7.5.1 cells 
and Huh7.5.1 infected with JFH1 for 3 days were treated with several pathway inhibitor including DPI, SB, 
SP, U0126, LY, AEBSF, IREstatin, and GSK at the concentration 20 μM for 24 hours. 1% DMSO was used as a 
negative control. Gene expression levels of spliced XBP-1, ATF3, and ATF4 were determined by real-time PCR 
and normalized to GAPDH. We found that HCV-induced XBP-1s mRNA expression enhancement reduced 
by DPI, SP, and IREstatin treatments in JFH1-infected Huh7.5.1 cells compared with DMSO control. HCV-
induced ATF3 and ATF4 mRNA expression enhancement was inhibited by DPI, SP, and GSK treatments, 
compared with DMSO control (Fig. 4A–C). *p < 0.05 for comparison of indicated treatment to the JFH1-
infected cells in DMSO. Whole cell lysates were analyzed by western blot to measure phospho-JNK, phospho-
IRE1, phospho-PERK, cleaved-ATF6, phospho-p38MAPK, and phospho-ERK. DPI decreased the HCV-
induced phosphorylation of JNK, IRE1, PERK, p38MARK, ERK and the cleaved form of ATF6. SP blocked 
HCV-induced IRE1, PERK phosphorylation and ATF cleavage (Fig. 4D). We added 20 μg of protein to each 
well to assure equal protein loading in each lane. Lane 1, Huh7.5.1 + DMSO; lane 2, JFH1 + DMSO; lane 3, 
JFH1 + DPI; lane 4, JFH1 + SP; lane 5, JFH1 + SB; lane 6, JFH1 + U0126; lane 7 JFH1 + AQ; lane 8, JFH1 + LY; 
lane 9, JFH1 + AEBSF; lane 10, JFH1 + IREstatin; lane 11, JFH1 + GSK.
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JNK (Fig. 7B, p = 0.022). NFκ B and TGF-β 1 luciferase signaling were partially blocked by JNK and IRE1 spe-
cific siRNAs (Fig. 7C, p = 0.026, and 0.038, respectively; Fig. 7D, p = 0.032, and 0.025, respectively). In contrast, 
the ROS, NFκ B, and TGF-β 1 responsive reporters were not blocked by ATF6 and PERK-specific knockdown 
(Fig. 7A–D), indicating that ATF6 and PERK are independent of TGF-β 1 induction.
siRNA-mediated knockdown of JNK and IRE1 blocks HCV up-regulation of NFκB and TGF-β1 
activation. RNA interference experiments were performed to assess the effects of JNK, IRE1, ATF6, and 
PERK knockdown on XBP1s, ATF3, ATF4, and TGF-β 1 mRNA levels. As expected, JNK and IRE1 silencing 
partially decreased HCV-induced TGF-β 1 (Fig. 8A, p = 0.039, and 0.035, respectively), and JNK siRNA blocked 
HCV-induced XBP1s, ATF3, and ATF4 mRNA expression enhancement in JFH1-infected cells (Fig. 8B–D). We 
found that IRE1 specific siRNA completely inhibited XBP1s mRNA expression but had no effect on ATF3 and 
ATF4 mRNA expressions. PERK specific siRNA did not affect TGF-β 1 and XBP-1 mRNA levels (Fig. 8A,B), 
but reduced ATF3 and ATF4 mRNA expression, suggesting that PERK is upstream of ATF3 and ATF4. In con-
trast, ATF6 and PERK siRNAs did not affect TGF-β 1, XBP1s, mRNA expression, indication that ATF6 and 
PERK are independent of the TGFB1 and ER stress pathways. We further examined the phosphorylation state 
of JNK1, IRE1, PERK, NFκ B, and ATF6 activation in HCV-infected JNK, IRE1, ATF6, and PERK knockdown 
Huh7.5.1 cells. As expected, immunoblotting showed that JNK siRNA decreased JFH1-induced IRE1 phospho-
rylation, PERK phosphorylation, ATF6 activation, and NFκ B phosphorylation. We found that each of the testes 
siRNAs did not affect cell viability (Fig. 9B). Additionally, IRE1 knockdown decreased NFκ B phosphorylation. 
The siRNA-mediated knockdown of ATF6 and PERK did not affect NFκ B activation (Fig. 9A). Taken together, 
Figure 5. ROS, JNK, and IRE1 inhibitor decreased HCV activated NFκB and TGF-β1. Huh7.5.1 cells and 
Huh7.5.1 infected with JFH1 for 3 days were transfected with plasmid pNFκ B or pSMAD-luciferase reporter 
for 24 hours. The pRL-TK expression Renilla luciferase was co-transfected as an internal control. After the 
transfection, cells were treated with several pathway inhibitor including DPI, SB, SP, U0126, LY, AQ, AEBSF, 
IREstatin and GSK (20 μM). 1% DMSO was used as a negative control. Luciferase signaling was monitored 
by a dual luciferase reporter assay at 24 hour after inhibitor treatment. Relative luciferase activity (RLA) was 
normalized by dividing the firefly luciferase value by the Renilla luciferase value. DPI, SB, SP, U0126, AQ, or 
IREstatin treatment decreased HCV-induced NFκ B and TGF-β 1 promoter signaling compared with DMSO 
control in JFH1 cells (Fig. 5A,B). TGF-β 1 mRNA level was determined by real-time PCR and normalized 
to GAPDH. We found that HCV-induced TGF-β 1 mRNA expression enhancement was blunted by DPI, 
SP, SB, U0126, AQ or IREstatin treatment compared with DMSO control in JFH1 cells (Fig. 5C). Whole cell 
lysates were analyzed by western blot to detect NFκ B phosphorylation. DPI, SP, SB, U0126, AQ and IREstatin 
decreased HCV induced NFκ B phosphorylation in JFH1 cells (Fig. 5D). Lane 1, Huh7.5.1 + DMSO; lane 
2, JFH1 + DMSO; lane 3, JFH1 + DPI; lane 4, JFH1 + SP; lane 5, JFH1 + SB; lane 6, JFH1 + U0126; lane 
7 JFH1 + AQ; lane 8, JFH1 + LY; lane 9, JFH1 + AEBSF; lane 10, JFH1 + IREstatin; lane 11, JFH1 + GSK. 
*p < 0.05 and **p < 0.01 for comparison of indicated and JFH1-infected cells.
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these findings indicate that HCV induces NFκ B and TGF-β 1 through a ROS production-JNK-IRE1 dependent 
pathway.
Discussion
HCV replication induces the formation of a membrane associated replication complex. Its replication activates 
ER stress and induces the UPR. HCV uses ER stress and manipulates the cellular response to ER stress to pro-
mote its persistence and pathogenesis. HCV-induced cellular responses may contribute to chronic liver disease 
by modulating cell proliferation, altering lipid metabolism, and potential oncogenic pathways. NFκ B activation 
is triggered by oxidative stress and ER stress in cells that support HCV replication24. Our previous work has 
demonstrated that HCV induces ROS and TGF-β 1 expression. HCV-mediated TGF-β 1 enhancement occurs 
through a ROS-induced and p38 MAPK, JNK, ERK1/2, NFκ B-dependent pathway22,23. TGF-β 1 expression has 
been implicated in the pathogenesis of liver fibrosis25. However, whether and how HCV-induced ER stress, UPR 
activation, and TGF-β 1 production are linked has not been established. The objective of our study was to deter-
mine whether HCV induces TGF-β 1 production through ER stress and UPR activation pathways using the cell 
culture infectious JFH1 HCV model.
In this study, we discovered that HCV induces ER stress and activates all three arms of the UPR through 
c-Jun N-terminal kinase (JNK). Additionally, we found that during HCV infection, the IRE1-XBP1 pathway 
is activated, as demonstrated by the presence of spliced XBP1 mRNA. We found that knockdown of JNK and 
IRE1-JFH1 cells decreased the expression of NFκ B and TGFβ 1. Given that the activation of the IRE1-XBP1 path-
way correlates with expression of NFκ B and TGF-β 1 in JFH1-HCV-infected cells, it therefore appears plausible 
that signaling through this pathway is important during HCV infection and implicates its involvement in HCV 
pathogenesis. To this end, it has been shown that UPR induced by HCV positively regulates HCV RNA replica-
tion in a cell culture system supporting efficient HCV propagation as abrogation of one of the three known UPR 
pathways suppresses HCV replication26. It is possible that the UPR induced by HCV perpetuates viral infection 
by relieving cells from stress conditions and facilitating replication. Additionally, we found that ER stress par-
tially contributes to HCV-induced NF-κ B activation and enhancement of TGF-β 1 expression via the IRE1 arm 
of the UPR. HCV infection has been linked to ER stress, which is associated with ROS production in patients 
with chronic infection27. Reactive oxygen species can induce the proliferation of hepatic stellate cells (HSCs) and 
release of TGF-β 1. Multiple studies have reported that ROS mediates activation of the p38 MAPK, JNK, ERK, 
and NFκ B pathways22. Our study provides new evidence, using an infectious tissue culture model, that HCV 
Figure 6. The comparison of ON-TARGET plus SMART pool siRNA and individual siRNA-mediated 
knockdown of JNK, IRE1, ATF6, and PERK. Huh7.5.1 cells were transfected with 25 nM small interference 
RNA (siRNA) against JNK, IRE1, ATF6 or PERK. After 48 hours of transfection, JNK, IRE1, ATF6, and PERK 
mRNA levels were determined by real-time PCR and normalized to GAPDH. The ON-TARGET plus SMART 
pool siRNAs had stronger mRNA knockdown effects for JNK, IRE1, ATF6, or PERK compared to its individual 
siRNA (Fig. 6A–D).
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induces ER stress and the UPR in a JNK-dependent manner. ER stress and UPR activation partially contribute to 
HCV-induced NFκ B activation and enhancement of TGF-β 1 expression.
We therefore propose a model in which HCV induces ROS induction, which in turn activates the phosphoryl-
ation of JNK. Phosphorylated JNK subsequently induces ER stress. The activation of one arm of the UPR pathway, 
IRE1, in turn induces the phosphorylation of NFκ B. The activated NFκ B translocates to nucleus and up-regulates 
TGF-β 1 expression (Fig. 10). This study provides insight into the intracellular signaling events in HCV infected 
cells and extends our knowledge regarding the mechanisms of ER stress, the UPR-pathway and TGF-β 1 activa-
tion. Our results further suggest that strategies to counteract HCV-associated liver pathogenesis could be directed 
against key intracellular events (ER stress and oxidative stress) induced by HCV.
Methods
Cell Culture. The human hepatocellular carcinoma cell line, Huh 7.5.1, was obtained from Dr. Frank Chisari, 
Scripps Institute, CA. Huh 7.5.1 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal calf serum and 100 units of penicillin/ml.
HCV infection. Cell supernatant containing the infectious JFH1 HCV virus was used to infect naïve Huh 
7.5.1 cells at appropriate dilutions (moi = 0.2) for luciferase reporter assays and RNA interference studies as pre-
vious descriptions28–30.
Reagents/Inhibitors. To study the impact of HCV infection on ER stress, NFκ B, and TGF-β 1 induc-
tion, inhibitors of intermediate steps were tested, including inhibitors of ROS (diphenyliodonium; DPI), p38 
MAP kinase (SB203580; SB), JNK (SP600125; SP), ERK1/2 (U0126), PI3K (LY294002; LY), NFκ B activation 
(6-amino-4-(4-phenoxyphenylethylamino; AQ), ATF6 (AEBSF), PERK (GSK2606414; GSK). These com-
pounds were obtained from Calbiochem, San Diego, CA. The IRE1 inhibitor Irestatin 9389 was obtained from 
Figure 7. siRNA-mediated knockdown of JNK and IRE1 inhibited JFH1 HCV-activated ER stress, NFκB 
and TGF-β1 luciferase activity. Huh7.5.1 cells and Huh7.5.1 infected with JFH1 for 3 days were transfected 
with 25 nM small interfering RNA (siRNA) against JNK, IRE1, ATF6 or PERK. After 48 hours of transfection, 
cells were transfected with pARE, pERSE, pNFκ B or pSMAD-luciferase reporter. ARE-mediated Nrf2, ERSE, 
pNFκ B or pSMAD signaling were monitored by a dual luciferase reporter assay system at 24 hours after 
luciferase reporter transfection. We found that ARE-mediated Nrf2 signaling was not blocked by JNK, IRE1, 
ATF6 or PERK-specific knockdown (Fig. 7A). ERSE luciferase signaling was blocked by JNK siRNA (Fig. 7B). 
The siRNA-mediated knockdown JNK and IRE1 inhibited HCV-activated NFκ B and SMAD luciferase activity 
in JFH1 cells compared to uninfected Huh7.5.1 cells (Fig. 7C,D). *p < 0.05 for comparison of indicated siRNA-
mediated knockdown and JFH1-infected cells.
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AxonMedchem, Netherlands. The inhibitors stock solution was dissolved in 1% dimethyl sulfoxide (DMSO) and 
1% used as a negative control. The cells were incubated with appropriate inhibitors at a final concentration of 
20 μM for 24 hours.
Luciferase Reporter Assays. Uninfected and HCV-infected Huh 7.5.1 cells were transfected with Cignal 
Antioxidant Response, ERSE, and SMAD Response Luciferase Reporters (SABiosciences, Frederick, MD) by 
using Fugene HD transfection reagent (Roche, Indianapolis, IN) according to the manufacturer’s protocol. 
NFκ B signaling was quantified using an NFκ B promoter construct expressing firefly luciferase (pNFκ B-Luc) 
and a construct expressing Renilla luciferase (pRL-TK) as an internal background control. The ARE reporter 
was designed to measure the transcriptional activity of the Nrf2 and Nrf1 transcription factors. Nrf2 and Nrf1 
act as sensors for oxidative stress and direct transcription from the antioxidant response element (ARE). The 
ERSE reporter construct monitored activity of the endoplasmic reticulum (ER) stress pathway. The ERSE is a 
motif that mediates the transcriptional response to ER stress. The NFκ B reporter construct was designed to 
monitor the activity of NFκ B-regulated signal transcription pathways. The NFκ B-responsive luciferase con-
struct encodes the firefly luciferase reporter gene under the control of a CMV promoter and tandem repeats of 
the NFκ B transcriptional response element (TRE). The SMAD reporter construct was designed to monitor the 
activity of TGF-β -induced signal transduction pathways. TGF-β signaling induces phosphorylation and activa-
tion of the SMAD2 and SMAD3 proteins, which then form complexes with SMAD4 and translocate to activate 
the expression of TGFβ -responsive genes. Cells were harvested and cellular lysates were analyzed for luciferase 
reporter assay kit (Promega, Madison, WI). Relative luciferase activity (RLA) was normalized by dividing the 
firefly luciferase value by the Renilla luciferase value.
RNA interference. Uninfected infected and JFH1 HCV-infected Huh7.5.1 cells were transfected with small 
interfering RNA (siRNA) against JNK, IRE1, ATF6, and PERK. A non-targeting siRNA was used as a negative 
control. The Dharmacon ON-TARGET plus SMART pool Human siRNAs (25 nM final concentration) (Fisher 
Scientific Life Science Research, Pittsburgh, PA) used for gene knock-down. The transfection protocol was 
Figure 8. siRNA mediated knockdown of JNK, IRE1 blunted HCV up-regulation of NFκB and TGF-β1 
activation. Huh7.5.1 cells and Huh7.5.1 cells infected with JFH1 for 3 days were transfected with 25 nM small 
interference RNA (siRNA) against JNK, IRE1, ATF6, and PERK for 48 hours. The mRNA expression levels 
of TGF-β 1, spliced XBP-1, ATF3, and ATF4 were determined by real-time PCR and normalized to GAPDH. 
We found that JNK siRNA or IRE1 siRNA blunted HCV-induced TGF-β 1 and XBP-1s mRNA enhancement 
in JFH1-infected Huh7.5.1 cells (Fig. 8A,B). JNK siRNA or PERK siRNA decreased HCV-induced ATF3 and 
ATF4 mRNA expression enhancement in JFH1-infected Huh7.5.1 cells (Fig. 8C,D). *p < 0.05 for comparison of 
indicated siRNA-mediated knockdown and JFH1-infected cells.
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performed according to the manufacturer’s instructions. Seventy-two hours after transfection knock-down effi-
ciency was assessed by real-time PCR and Western blotting from lysate of siRNA-transfected cells.
Analysis of Gene Expression by Quantitative Real-time PCR. Total cellular RNA was isolated 
using the QIA Shredder and RNeasy kit (Qiagen, Valencia, CA), as described by the manufacturer’s proto-
col. Reverse transcription was performed using Applied Biosystems high-capacity cDNA reverse transcrip-
tion kits (Invitrogen, Carlsbad, CA) with random primers. To quantify gene expression, quantitative real-time 
PCR was performed in the Bio-Rad IQ5 system (Bio-Rad Laboratories, Hercules, CA) using Finnzymes SYBR 
green I dye (New England Biolabs, Ipswich, MA), and sequence-specific primers, as indicated in Table 1. The 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as an internal control. The reactions were 
performed under the following conditions: 95 °C for 3 min, followed by 45 cycles at 94 °C for 20 seconds, 60 °C for 
Figure 9. siRNA mediated knockdown of JNK, IRE1 blunted HCV up-regulation of NFκB activation. 
Huh7.5.1 cells and Huh7.5.1 cells infected with JFH1 for 3 days were transfected with 25 nM small interference 
RNA (siRNA) against JNK, IRE1, ATF6, and PERK. After 48 hours, the expression of phospho-JNK, phospho-
IRE1, phospho-PERK, ATF6 cleavage and phospho-NFκ B were analyzed by western blot. JNK siRNA decreased 
JFH1-induced IRE1, PERK, NFκ B protein phosphorylation and ATF6 activation. IRE1 knockdown decreased 
HCV-induced NFκ B phosphorylation in JFH1-infected Huh7.5.1 cells (Fig. 9A). We added 20 μg of protein 
to each well to assure equal protein loading in each lane. Lane 1, Huh7.5.1; lane 2, JFH1 + NTsiRNA; lane 3, 
JFH1 + JNKsiRNA; lane 4, JFH1 + IRE1siRNA; lane 5, JFH1 + ATF6siRNA; lane 6, JFH1 + PERKsiRNA. We 
found that siRNA knockdown of the tested genes did not affect cell viability compared to negative control 
siRNA (Fig. 9B).
Gene Name Forward Primer 5′- 3′ Reverse Primer 5′- 3′
XBP1s CTGAGTCCGCAGCAGGTG TGCCCAACAGGATATCAGACT
ATF3 TTGCAGAGCTAAGCAGTCGTG ATGGTTCTCTGCTGCTGGGATTCT
ATF4 CCTTCGACCAGTCGGGTTTG CTGTCCCGGAAAAGGCAT
TGF-β1 GGCCAGATCCTGTCCAAGC GTGGGTTTCCACCATTAGCAC
JFH1 TCTGCGGAACCGGTGAGTA TCAGGCAGTACCACAAGGC
GAPDH ACAGTCCATGCCATCACTGCC GCCTGCTTCACCACCTTCTTG
Table 1.  List of primers used for real time PCR.
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30 seconds, and 72 °C for 20 seconds. The mRNA level of each gene was normalized to GAPDH levels to obtain 
mRNA arbitrary units (fold change).
Western Blot Analysis. Cells were washed with phosphate-buffered saline (PBS) and lysed in radioimmu-
noprecipitation assay (RIPA) buffer (50 mM Tris-HCl [pH7.4], 150 mM NaCl, 1% NP-40, 0.5% Sodium deox-
ycholate, 0.1% SDS, 5 mM EDTA) containing protease and phosphatase inhibitor cocktail (Sigma-Aldrich, St. 
Louis, MO) as previous description31,32. Cell lysates were sonicated and cleared by centrifugation at 14,000 rpm 
for 15 min at 4 °C. Protein concentration was determined and samples were boiled at 95 °C for 5 min in SDS-PAGE 
sample buffer. Twenty micrograms of protein were loaded into each well and were separated on a NuPAGE Novex 
precast 4-to-12% gradient Bis-Tris gels (Invitrogen, Carlsbad, CA) using the SDS-PAGE technique. The proteins 
were transferred to nitrocellulose membranes and blocked with 5% bovine serum albumin (BSA) in TBS/Tween. 
The blotted membranes were probed overnight at 4 °C with specific primary antibodies. The secondary antibod-
ies used were horseradish peroxidase (HRP)-conjugated ECL donkey anti-rabbit IgG and HRP-conjugated ECL 
sheep anti-mouse IgG (Amersham Biosciences, Piscataway, NJ). Chemiluminescence detection of the bands was 
performed using the ECL Western blotting detection kit (Amersham Biosciences, Piscataway, NJ). Membranes 
were probed with anti-actin (Sigma-Aldrich, St. Louis, MO) to confirm equal loading.
Cell proliferation assay. Cell proliferation was analyzed by using the Cell Counting Assay Kit-8 (CCK-8) 
(Dojindo Molecular Technologies, Gaithersburg, MD) according to the manufacturer’s protocol. At 6, 12, 24, 
or 48 hours post inhibitor treatment or transfection, the cells were washed with PBS. Ten microliters of CCK-8 
solution was added to each well, the cells were incubated for 1 hour, and the absorbance at 490 nm was measured 
using the automatic multiwall spectrophotometer (Bio-Rad, Richmond, CA). Experiments were performed in 
triplicate with representative data presented.
Antibodies. Each of the primary antibodies were used according to the manufacturer’s protocol: 
Phospho-JNK #4671, JNK #9252, IRE1α #3294, PERK #5683, phospho-p38 MAPK #9215, p38 MAPK #9212, 
phospho-p44/42 MAPK #9106, p44/42 MAPK #4695, (Cell Signaling, Danvers, MA). phospho- IRE1α #PA1-
16927, phospho-PERK #MA5-15033, and HCV core (Thermo Scientific, Rockford, IL). ATF6 #ab11909 (Abcam, 
Cambridge, MA).
Statistical Analysis. Statistical analysis was conducted using the 2-tailed Student t test. Data are expressed 
as means ± standard deviations (S.D.). Triplicate determinations were performed in all real-time experiments, 
and all experiments were repeated at least three times.
Figure 10. Proposed model by which HCV infection induces NFĸB and TGF-β1 through ER stress and 
the UPR pathway in a JNK-dependent manner. HCV induces ROS induction, which in turn activates the 
phosphorylation of JNK. The phosphorylated JNK subsequently induces ER stress. The activation of one arm of 
UPR pathway, IRE1, induces the phosphorylation of NFκ B. The activated NFκ B is translocated to nucleus and 
up-regulates TGF-β 1 expression.
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